Ayala Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q3 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Ayala Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q3 2011 to Q4 2023.
  • Ayala Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $136M, a 251% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $136M +$96.9M +251% Dec 31, 2023 10-K 2024-04-16
Q4 2022 $38.7M Dec 31, 2022 10-K 2024-04-16
Q3 2022 $67.9M +$5.28M +8.44% Oct 31, 2022 10-K 2023-02-10
Q3 2021 $62.6M -$272K -0.43% Oct 31, 2021 10-K 2023-02-10
Q3 2020 $62.8M +$6.02M +10.6% Oct 31, 2020 10-K 2022-02-14
Q3 2019 $56.8M -$31M -35.3% Oct 31, 2019 10-K 2021-01-22
Q3 2018 $87.9M -$16.9M -16.1% Oct 31, 2018 10-K 2019-12-20
Q3 2017 $105M +$35.4M +51.1% Oct 31, 2017 10-K 2019-01-11
Q3 2016 $69.3M +$21.9M +46% Oct 31, 2016 10-K 2017-12-21
Q3 2015 $47.5M +$16.4M +52.6% Oct 31, 2015 10-K 2017-01-09
Q3 2014 $31.1M +$4.77M +18.1% Oct 31, 2014 10-K 2016-01-08
Q3 2013 $26.3M +$3.93M +17.5% Oct 31, 2013 10-K 2015-01-06
Q3 2012 $22.4M +$11.8M +111% Oct 31, 2012 10-K 2014-01-29
Q3 2011 $10.6M Oct 31, 2011 10-K/A 2013-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.